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Abstract— Multiple Sclerosis (MS) is an unpredictable, often 
disabling disease that can adversely affect any body function; 
this often requires persons with MS to be active patients who 
are able to self-manage. There are currently thousands of 
health applications available but it is unknown how many 
concern MS. We conducted a systematic review of all MS apps 
present in the most popular app stores (iTunes and Google 
Play store) on June 2016 to identify all relevant MS apps. After 
discarding non-MS related apps and duplicates, only a total of 
25 MS apps were identified. App description contents and 
features were explored to assess target audience, 
functionalities, and developing entities. The vast majority of 
apps were focused on disease and treatment information with 
disease management being a close second. This is the first 
study that reviews MS apps and it highlights an interesting gap 
in the current repertoire of MS mHealth resources. 
 
mHealth, multiple sclerosis, mobile applications, systematic 
review; health apps 
I.  INTRODUCTION 
Multiple sclerosis (MS) is one of the world’s most 
common neurologic disorders, and in many countries it is the 
leading cause of non-traumatic neurologic disability in 
young adults[1]. MS is an unpredictable, often disabling 
disease of the Central Nervous System (CNS) that can 
adversely affect any body function. However, the most 
common symptoms are overwhelming fatigue, visual 
disturbances, altered sensation and difficulties with mobility. 
Pharmacological treatment of the condition is required but 
there are many medications and other strategies to manage 
MS symptoms such as spasticity, pain, bladder problems, 
fatigue, sexual dysfunction, weakness, and cognitive 
problems. MS complexity often requires persons with MS to 
be active patients and able to self-manage[2]. 
New technologies have indirectly created a new type of 
patient that many healthcare providers have seen during 
consults, a patient that is well informed, equipped with 
electronic communication tools and committed to participate 
on their own care; an e-patient [3]. This technical growth not 
only affects patients but the healthcare ecosystem as well. 
Connected Health is a new model of health management in 
which, with the support of the new technologies the patient 
becomes the center of the health care system[4]. The delivery 
of healthcare or health related services through the use of 
mobile devices or application, also known as mHealth[5], is 
included in the Connected Health model. There are currently 
thousands of mHealth applications[6] available in app stores 
which has caused researchers to systematically study them 
(ie Cancer[7], [8]; HIV[9]; Diabetes[10]; etc.). The absence 
of healthcare professionals involvement in app development 
continues to be raised time and time again. These concerns 
revolve around app design and app content alike [11]–[15].  
No study has been done for MS apps to this date and the 
types of mHealth applications available, the intended 
audience and who are developing apps for this condition are 
currently unknown. This work describes the current 
landscape of MS apps and characterizes them based on their 
features and target audiences. 
II. METHODS 
A. Study Design 
A cross-sectional study of MS apps was performed to 
characterize apps from the two major smartphone app stores: 
iTunes App Store and Google Play Store, which together 
represent more than 98.9% of the smartphone app market 
share[16]. Both stores were systematically searched to 
identify all relevant apps and provide a systematic 
presentation and synthesis of the characteristics of the apps. 
The complete flow of this study is shown in Figure 1. 
B. Setting 
The iTunes App Store serves as the official app store for 
iOS and has 2 million apps available as of June 2016 [17]. 
Google Play store (originally the Android Market) serves as 
the official app store for the Android operating system with 
over 2.2 million apps available as of June 2016 [17]. On June 
17th 2016, iTunes App[18] and Google Play[19] stores from 
the United States were searched for apps with the keywords 
“multiple sclerosis” using the audience targeting platform 
42matters [20] which aggregates mobile applications data 
and meta-data across the iOS and Google Play stores.  
C. Selection Criteria 
All apps that were a partial or complete match for the 
search terms “multiple sclerosis” and the title and/or app 
store description referred MS or MS related conditions were 
initially included. Basic and “premium” versions of the same 
app were considered as separate entries as were versions of 
the same app for different operating systems. This distinction 
was considered because of the phenomenon of mobile device 
fragmentation in which different versions of the same app 
must co-exist were due to version capabilities or store 
submission processes. This distinction is also common 
practice in this type of systematic app reviews[7]. 
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Figure 1.  Study Flow. 
A small sample (10%) was randomly produced and two 
reviewers with mHealth experience (GG and EGF) 
independently evaluated the eligibility of the apps against the 
selection criteria. In order to assess clarity of the selection 
criteria, inter-rater reliability was assessed using Fleiss-
Cohen’s Coefficient. Disagreements were resolved by 
consensus involving a third reviewer when necessary. After 
validating the selection criteria and determining inter-rater 
reliability, the rest of the apps were examined.  
GG and EGF independently reviewed the information 
extracted using structured forms with app title and store 
descriptions. In cases where these didn’t provide enough 
information, app or developer’s websites were visited to 
extract information on: origin (eg, healthcare related 
agencies, non-governmental organizations, universities, etc), 
features and intended audiences.  
1) Inclusion Criteria 
 title and/or description is about MS or MS related 
conditions 
2) Exclusion Criteria 
 title and/or description is not written in English 
 duplicates from the same store 
D. Data Extraction 
Data matching the keywords was automatically extracted 
from the store description of the app using the software 
application 42matters[20]. Data extracted included app 
information on: year of release, costs, downloads, ratings, 
title of app, app description, categories, tags, languages, app 
websites, screenshots, etc.  
E. Data Coding and Classification 
Apps were classified based on their main purpose as 
described in the store description into only one category 
following our classification scheme. If the purpose of the app 
was not clear from the description, a proper classification 
was discussed among reviewers until consensus was reached.  
F. App Purpose 
The app purpose classification scheme is as follows: 
 Awareness-raising: tools to raise public recognition 
of MS as a problem, tools for fundraising, etc.  
 Disease and treatment information: provide general 
information about MS (eg, disease or treatment 
options) 
 Disease management: provide information and 
practical tools to deal with the medical, behavioral, 
or emotional aspects of MS. 
 Physical Rehabilitation: provide information and 
practical tools to deal with the medical, behavioral, 
or emotional aspects of MS. 
 Support: provide access to peer or professional 
assistance.  
G. App Origin 
In order to understand how the mHealth developer 
ecosystem is composed we analyzed and coded the apps 
based on title, description and developer and/or uploading 
entity using the following criteria: 
 Healthcare related Agency (HCA): hospitals, clinics, 
pharmaceutical corporations or governmental 
organizations directly related to healthcare (ie Public 
Health branches). 
 Governmental Agency (GOV): any governmental 
agency or organization not directly involved in 
healthcare (ie IT departments). 
 Non-governmental Agency (NGO): any organization 
that is neither a part of a government nor a 
conventional for-profit business such as societies or 
organizations that specialize both in general health 
improvement as well as illness-specific objectives 
and offer support groups (ie Patient Empowerment 
Organizations). 
 Educational Organizations (EDU): any educational 
organization such as Universities, Colleges, 
Libraries or Schools not directly related to healthcare 
(ie Science School Projects) 
 Conferences and Journals (CONF): scientific 
journals, patient and/or medical conferences. 
 Small and Medium-sized Enterprises (SME): 
startups, software developing companies or any 
other private organizations that identified themselves 
as an enterprise and not individuals (ie Digital 
Health Startups). 
 Individuals (IND): developers or uploader entities 
who are listed as individuals or have not identified 
themselves as enterprises (ie John Smith). 
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Whenever discrepancies were found between 
descriptions and developer or uploading entities, description 
was considered instead. 
H. App Target Audience 
The app descriptions were analyzed to assess intended 
target audience and coded based on the following criteria: 
 Patient-oriented: intended to be used by the general 
public, patients and/or their family members.  
 Clinician-oriented: intended to be used by healthcare 
professionals or students from health related fields. 
I. Statistical Methods 
Categorical variables are presented as absolute and 
relative frequencies. Continuous variables are presented as 
mean and standard deviation or median with interquartile 
range depending on distribution. Landis & Koch’s standards 
for Fleiss-Cohen’s Coefficient are used[21]. Statistical 
analysis was performed using STATA v13. 
III. RESULTS 
A. Selection 
A total of 1,622 apps matched the search terms of 
“multiple sclerosis”, of which 68 matches were from the 
iTunes App Store and 1,554 from the Google Play Store. A 
random sample (n=168) was independently reviewed by two 
reviewers (GG and EGF) following the selection criteria. 
Inter-rater reliability was determined using Cohen’s Kappa 
and found to be more than acceptable at 0.84 (SE 0.03 CI 
95% 0.78 – 0.89). One reviewer continued the 
inclusion/exclusion process with the rest of the apps 
(n=1,454). After removing duplicates and going through the 
selection criteria only 25 apps remained (15 for iOS and 10 
for Android).  
B. Classification 
Table I shows a description of the app population that we 
explored. The vast majority of MS apps were free (92%) 
with only 2 iOS apps requiring payment. Android MS apps 
were rated more often than iOS MS apps. 
In terms of MS app functionality, disease and treatment 
information apps are largely prevalent (close to 70% of all 
apps); disease management apps are second (almost 25%); 
awareness raising and support apps are a minority. No 
physical rehabilitation apps were present. See Table II. 
Android MS apps were mostly intended for patients but 
in iOS apps were more evenly distributed between patient 
and clinician oriented MS apps. See Figure 2 for some 
examples of MS apps. 
Table III shows the different developing entities by 
operating system. Small and medium sized enterprises such 
as start-ups or software companies were responsible for the 
development of more than half of all MS apps (52%); while 
a quarter were conferences and publishing agencies (24%). 
No app was developed by governmental agencies. Table IV 
shows how MS apps are distributed in terms of their 
intended audience. 
All MS apps found are shown in Table V as is their type 
of app and app store URL. 
 
  
Figure 2.  Examples of MS apps. Left: Multiple Sclerosis Diagnosis & 
Management. Right: MSAA - My MS Manager. 
TABLE I.  BASIC APP CHARACTERISTICS 
 Android iOS 
n 10 (100%) 15 (100%) 
Free 
Paid 
10 (100%) 
- 
13 (86%) 
2 (14%) 
Rated 9 (90%) 5 (33%) 
Rating 
0 
1 
2 
3 
4 
5 
 
 
1 (10%) 
- 
- 
1 (10%) 
8 (80%) 
- 
 
 
10 (66%) 
- 
1 (6%) 
2 (14%) 
2 (14%) 
- 
Number of downloads 
10-50 
100-500 
500-1000 
1000-5000 
Not Available 
 
1 (10%) 
1 (10%) 
4 (40%) 
4 (40%) 
 
- 
- 
- 
- 
- 
15 
All percentages are rounded up in accordance with formatting guidelines 
TABLE II.  APP FUNCTIONALITY BY OPERATING SYSTEM 
 Android iOS 
Awareness-raising 1 (10%) - 
Disease and treatment information 6 (60%) 11 (73%) 
Disease management 3 (30%) 3 (20%) 
Physical Rehabilitation - - 
Support - 1 (7%) 
All percentages are rounded up to follow formatting guidelines 
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TABLE III.  DEVELOPING AGENCY BY OPERATING SYSTEM 
 Android iOS 
Healthcare related Agency 1 (10%) 1 (7%) 
Governmental Agency - - 
Non-governmental Agency 1 (10%) - 
Educational Organizations - 2 (14%) 
Conferences and Journals 1 (10%) 5 (33%) 
Small and Medium-sized Enterprises 6 (60%) 7 (46%) 
Individuals 1 (10%) - 
All percentages are rounded up to follow formatting guidelines 
TABLE IV.  APPLICATION TARGET AUDIENCE 
 Android iOS 
Patient-oriented 9 (90%) 6 (40%) 
Clinician-oriented 1 (10%) 9 (60%) 
All percentages are rounded up to follow formatting guidelines 
IV. DISCUSSION 
A. Principal Findings 
Persons with MS have a prolonged median survival time 
from the time of diagnosis of around 40 years[22]. Therefore 
issues regarding progressive physical and cognitive 
disability, psychosocial adjustment and social re-integration 
progress over time. These have implications for persons with 
MS, their care givers, treating clinicians and society as a 
whole, in terms of healthcare access, provision of services 
and financial burden[23], [24]. Many authors have advocated 
that Smartphone applications have the potential to increase 
efficiency within medical practice and can provide 
constantly updated clinical evidence[5], [25]–[28].  
To our knowledge, this is the first review of MS mobile 
applications commercially available to patients, health 
professionals and public in general. Our study describes the 
different app functionalities; the proportion of each type; 
intended audiences; and developing entities. 
Considering that MS is one of the world’s most common 
neurologic disorders, how few MS apps are in the app stores 
(n=25) is in stark contrast with the reality for other 
conditions such as cancer (n=295 in 2013) [7], diabetes 
(n=137 in 2009) [29] or HIV (n=124 in 2013) [30] among 
others. 
According to our study, applications for healthcare 
professionals vary in content, ranging from information for 
the diagnosis, classification and disease management to 
educational purposes such as clinical case reports and MRI 
presentations, conferences, online training and journal apps. 
On the other hand, patients’ apps had a more narrow scope 
focusing on symptoms information, disease management and 
only one patient support tool through social networks.  
The change in distribution, as seen in Table IV, between 
patient-oriented and clinician-oriented apps depending on the 
operating system is intriguing. For other conditions patient-
oriented applications usually outnumber those intended for 
clinicians[7], [31].  
The major contributors to the mobile application 
ecosystem for persons with MS are start-ups and 
entrepreneurs. It is of note that no governmental agency has 
launched to market an mHealth solution for MS. Equally 
interesting is the absence of healthcare provider involvement 
in app development. Especially considering that the medical 
community has risen concerns around non-medical personnel 
promoting app design and development [11]–[15]. It would 
seem essential that expert medical personnel be involved in 
the creation of medical apps yet healthcare professionals are 
seldom involved. 
Store’s star rating systems and download ranges are 
frequently used to indicate popularity and indirectly measure 
the “success” of these apps. However, using those as criteria 
yields little or no meaningful information on app quality as 
has been discussed on occasions[32]. The lack of 
standardized quality measures continues to be concerning, as 
app use carries risk and can lead to adverse outcomes for 
both patients and clinicians[33]–[35]. 
B. Limitations 
One limitation this study has lies in the keyword 
selection; making it possible for relevant applications to have 
been unintentionally excluded from our search results. While 
it’s possible that MS might be featured in applications 
devised for a broader range of conditions (eg. 
Neurodegenerative Diseases apps), users looking for MS 
apps would most likely be looking for apps specific to the 
condition. 
The selection of United States app stores only might also 
have excluded relevant apps. Using Android and iOS based 
applications exclude the presence of less popular 
Smartphone platforms like Windows or Blackberry. Google 
Play and iTunes stores have intrinsic differences that make it 
difficult to compare certain attributes like number of 
downloads per app for example. It’s also important to note 
that iTunes App Store and Google Play Store have different 
processes and steps for app submission which may influence 
app development. Choosing to focus on only English 
language applications probably also excluded relevant MS 
apps from this review. 
V. CONCLUSSIONS 
There is an interesting gap in the current repertoire of 
mHealth solutions for persons with MS. It could prove 
important to address this as it might be a channel to reach 
persons with MS in a way that’s engaging and empowers 
them. Empowered persons with MS can be more active in 
their own health management and decision making process.  
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TABLE V.  APPLICATION TARGET AUDIENCE 
Type Name of the app App store URL 
Awareness-raising Overcoming Multiple Sclerosis 
https://play.google.com/store/apps/details?id=com.a11663794335124b9dce
47b98a.a92180565a 
Disease and treatment 
information 
Multiple Sclerosis News https://play.google.com/store/apps/details?id=com.multiple.sclerosis.news 
Multiple Sclerosis Treatment 
https://play.google.com/store/apps/details?id=revolxa.inc.multiplesclerosist
reatment 
Multiple Sclerosis Symptoms 
https://play.google.com/store/apps/details?id=com.inc.multiplesclerosissym
ptoms 
Multiple Sclerosis Information 
https://play.google.com/store/apps/details?id=multiple.sclerosis.causes.dise
ases.symptoms.prevention.medicine 
Multiple Sclerosis Attack App 
https://play.google.com/store/apps/details?id=com.cloudninedevelopmentll
c.MSAttack 
Multiple Sclerosis Symptoms 
https://play.google.com/store/apps/details?id=com.healthappstudio.multipl
esclerosissymptoms 
Multiple Sclerosis Diagnosis & 
Management 
https://itunes.apple.com/us/app/multiple-sclerosis-diagnosis-
management/id480116542?mt=8 
Multiple Sclerosis Attack App 
https://itunes.apple.com/us/app/multiple-sclerosis-attack-
app/id883546897?mt=8 
eMultipleSclerosis Review 
https://itunes.apple.com/us/app/emultiplesclerosis-
review/id983062229?mt=8 
Multiple Sclerosis and Related Disorders 
https://itunes.apple.com/mx/app/multiple-sclerosis-
related/id686600160?mt=8 
MULTIPLE SCLEROSIS - NHS 
DECISION AID 
https://itunes.apple.com/app/multiple-sclerosis-nhs-
decision/id585689063?mt=8&ign-mpt=uo%3D4 
Multiple Sclerosis Virtual Education 
Academy 
https://itunes.apple.com/us/app/multiple-sclerosis-virtual-education-
academy/id965247008?mt=8 
Multiple Sclerosis Monitor and 
Commentary 
https://itunes.apple.com/ro/app/multiple-sclerosis-monitor-and-
commentary/id684850546?mt=8 
Medikidz Explain Multiple Sclerosis 
https://itunes.apple.com/us/app/medikidz-explain-multiple-
sclerosis/id1011110811?mt=8 
Miniatlas Multiple Sclerosis 
https://itunes.apple.com/us/app/miniatlas-multiple-
sclerosis/id393496454?mt=8 
Symptoms Of Multiple Sclerosis 
https://itunes.apple.com/us/app/symptoms-of-multiple-
sclerosis/id1081604312?l=es&mt=8 
2014 Annual conference in multiple 
sclerosis 
https://itunes.apple.com/do/app/2014-annual-conference-
in/id865277898?mt=8 
Disease management 
MS self Multiple Sclerosis App https://play.google.com/store/apps/details?id=com.acorda.msself 
My Multiple Sclerosis Diary https://play.google.com/store/apps/details?id=com.appxient.mymsdiary 
Multiple Sclerosis EDSS Trackr https://play.google.com/store/apps/details?id=com.edss 
Multiple Sclerosis @Point of Care™ 
https://itunes.apple.com/us/app/multiple-sclerosis-point-of-
care/id368515953?mt=8 
MS self – Multiple Sclerosis Mobile App 
for MS Patients 
https://itunes.apple.com/us/app/ms-self-multiple-sclerosis-app-for-ms-
patients/id744421921?mt=8 
Multiple Sclerosis - MedImage Cases 
https://itunes.apple.com/us/app/multiple-sclerosis-medimage-
cases/id482713606?mt=8 
Support MyMSTeam: The social network for those 
who have multiple sclerosis 
https://itunes.apple.com/py/app/mymsteam-social-network-
for/id628041222?mt=8 
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